SereNeuro Therapeutics

Private

Baltimore, MarylandHealthcare & Life Scienceshttps://sereneuro.com/

Last Round

Grant

May 13, 2025

Total Funding Raised

$5.02M

Company Overview

SereNeuro Therapeutics is a biotechnology company developing non-opioid cell and gene therapies for chronic pain management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

cell therapynon-opioid pain treatmentinduced pluripotent stem cellsiPSCchronic pain treatmentpreclinical biotechopioid alternativedisease-modifying therapyregenerative medicineosteoarthritis treatmentpain sponge technologyneuropathic painDMOADbiologic therapynociceptors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SereNeuro Therapeutics Comps

Public and private peers based on sector, stage, and business model.

SereNeuro Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SereNeuro Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 13, 2025
Seed	Feb 28, 2025
Grant	Nov 20, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Daniel Saragnese

CEO, Co-Founder

Founding Team

SereNeuro Therapeutics Investors

Notable investors and investment history

SereNeuro Therapeutics investors
Investor	Rounds
Johns Hopkins Technology Ventures	Grant
Maryland Stem Cell Research Fund	Grant
Ecphora Capital	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 13, 2025
Received funding from the Maryland Stem Cell Research Fund.
Feb 28, 2025
$5M round led by Ecphora Capital

View all signals

SereNeuro Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SereNeuro Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SereNeuro Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland

Employee Range6

Year Founded2023

Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.